New England Asset Management Inc Organon & Co. Transaction History

New England Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $5,358 - $7,843	229 New	229 $5,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $1,899 - $2,334	-60 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $1,674 - $2,164	-55 Reduced 47.83%	60 $2,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $195,285 - $243,100	-6,821 Reduced 98.34%	115 $4,000
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $197,329 - $263,568	6,936 New	6,936 $209,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on New England Asset Management Inc with notifications on news.